RGS-6xHis-BLIMP-1-pcDNA3.1- Citations (4)
Originally described in: DRE-1/FBXO11-Dependent Degradation of BLMP-1/BLIMP-1 Governs C. elegans Developmental Timing and Maturation.Horn M, Geisen C, Cermak L, Becker B, Nakamura S, Klein C, Pagano M, Antebi A Dev Cell. 2014 Mar 4. pii: S1534-5807(14)00069-0. doi: 10.1016/j.devcel.2014.01.028. PubMed Journal
Articles Citing RGS-6xHis-BLIMP-1-pcDNA3.1-
Articles |
---|
Interleukin 21 Receptor/Ligand Interaction Is Linked to Disease Progression in Pancreatic Cancer. Linnebacher A, Mayer P, Marnet N, Bergmann F, Herpel E, Revia S, Yin L, Liu L, Hackert T, Giese T, Herr I, Gaida MM. Cells. 2019 Sep 18;8(9). pii: cells8091104. doi: 10.3390/cells8091104. PubMed |
LDB1 and the SWI/SNF complex participate in both transcriptional activation and repression by Caenorhabditis elegans BLIMP1/PRDM1. Fong HT, Hagen T, Inoue T. Biochim Biophys Acta Gene Regul Mech. 2020 Sep;1863(9):194577. doi: 10.1016/j.bbagrm.2020.194577. Epub 2020 May 14. PubMed |
Improving the secretory capacity of CHO producer cells: The effect of controlled Blimp1 expression, a master transcription factor for plasma cells. Kim SH, Baek M, Park S, Shin S, Lee JS, Lee GM. Metab Eng. 2022 Jan;69:73-86. doi: 10.1016/j.ymben.2021.11.001. Epub 2021 Nov 11. PubMed |
O-GlcNAcylation of Blimp-1 in Lymphocytes Inhibits Its Transcriptional Function and Is Associated with Migration and Invasion of Breast Cancer Cells. Chen YF, Shao GC, Li J, Yang AQ, Li J, Ye XS. Mol Cancer Res. 2022 Apr 1;20(4):650-660. doi: 10.1158/1541-7786.MCR-21-0405. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.